- Critical care
- Infectious Diseases
- Mental Health
- Metabolic and Endocrine
- Musculoskeletal Health
- Neuroprogressive and Dementia
- Oral and Dental
- Primary Care
- Regenerative Medicine
- Reproductive Health and Childbirth
Dementia and Neurodegenerative Studies
The Dementia and Neurodegenerative Network supports studies which are funded by an NHS Research Scotland Eligible Funder list. All Scottish research ongoing within the network is registered on the UK Clinical Trials Gateway website. If you would like to find out more about our portfolio or are interested in recruiting to any of our studies please email Tay-UHB.SDCRNteam@nhs.net.
We support a wide range of research studies conducted within the NHS, at Scottish Universities and in Care Home settings. These include observational studies, genetic studies, drug trials, questionnaire studies and brain tissue banking.
These studies can be entered using the online register Join Dementia Research.
You can also contact our staff in your local area:
- Jacqueline Kerr (Lothian) firstname.lastname@example.org
- Catriona McNeill (Glasgow & Clyde) email@example.com
- Justine Hudson (Tayside) firstname.lastname@example.org
- Emma Darling (Grampian) email@example.com
- Ian Shread (Highland) firstname.lastname@example.org
- Bernie McInally (Borders) Bernie.McInally@borders.scot.nhs.uk
Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)
A new study "Improving diagnostic and care pathways in progressive supranuclear palsy and corticobasal degeneration" conducted by Dr. Diane Swallow, a Neurology Registrar and Clinical Research Fellow based at the University of Aberdeen, seeks to involve people from across Scotland living with progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD).
The study will look at the routes to diagnosis and care pathways of people with PSP and CBD to find out how diagnosis and care could be improved. It will also involve the carers or families of people with PSP and CBD, to find out the support that carers of people with PSP or CBD require.
The study is open to everyone in Scotland with PSP or CBD, at all stages of their condition. Individuals with fronto-temporal dementia (FTD), or their next of kin/guardian, are also invited to contact the study team to discuss their eligibility for the study, as a small number of individuals with FTD may have underlying PSP or CBD.